APA (7th ed.) Citation

S, P., A, J., D, G., R, J., C, J., JL, H., . . . G, C. (2025). Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer. Cancer chemotherapy and pharmacology, 95(1), 115. https://doi.org/10.1007/s00280-025-04840-2

Chicago Style (17th ed.) Citation

S, Perimbeti, et al. "Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-resistant Prostate Cancer." Cancer Chemotherapy and Pharmacology 95, no. 1 (2025): 115. https://doi.org/10.1007/s00280-025-04840-2.

MLA (9th ed.) Citation

S, Perimbeti, et al. "Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-resistant Prostate Cancer." Cancer Chemotherapy and Pharmacology, vol. 95, no. 1, 2025, p. 115, https://doi.org/10.1007/s00280-025-04840-2.